Helen joined Certara (formerly Quantitative Solutions) in January 2015 after 10 years as a pharmacometrics consultant with the Pharsight Consulting Services group (now Certara). She has expertise in population pharmacokinetic/pharmacodynamic modeling and simulation in a variety of therapeutic areas. She is well-published in the area of PK/PD modeling to inform strategic decision-making in drug development and in clinical practice.
Helen has a background in academia, having held faculty positions at The University of Illinois at Chicago and The University of Queensland, Australia. She received BPharm with Honors and PhD degrees in Pharmaceutical Sciences from The University of Queensland and pursued postdoctoral fellowships in clinical pharmacology at Stanford University School of Medicine and in PK/PD modeling at University of California, San Francisco.